Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

ClinicalTrials.gov ID: NCT00279045

Public ClinicalTrials.gov record NCT00279045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.

Study identification

NCT ID
NCT00279045
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
4,426 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2000 (Type not available)
Primary completion
Jun 1, 2006 (Actual)
Completion
Jun 19, 2006 (Actual)
Last update posted
Nov 29, 2017

2000 – 2006

United States locations

U.S. sites
178
U.S. states
40
U.S. cities
135
Facility City State ZIP Site status
GSK Investigational Site Anniston Alabama 36207 —
GSK Investigational Site Birmingham Alabama 35233 —
GSK Investigational Site Mesa Arizona 85206 —
GSK Investigational Site Tucson Arizona 85723 —
GSK Investigational Site Little Rock Arkansas 77205 —
GSK Investigational Site Berkeley California 94705 —
GSK Investigational Site Corona California 92879 —
GSK Investigational Site Fair Oaks California 95628 —
GSK Investigational Site Fremont California 94538 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Fullerton California 92835 —
GSK Investigational Site Greenbrae California 94904 —
GSK Investigational Site Harbor City California 90710 —
GSK Investigational Site Healdsburg California 95448 —
GSK Investigational Site La Jolla California 92037 —
GSK Investigational Site Loma Linda California 92354 —
GSK Investigational Site Los Angeles California 90059 —
GSK Investigational Site Los Angeles California 90095 —
GSK Investigational Site Modesto California 95355 —
GSK Investigational Site Pasadena California 91105 —
GSK Investigational Site San Diego California 92126 —
GSK Investigational Site San Francisco California 94143 —
GSK Investigational Site Santa Rosa California 95405 —
GSK Investigational Site Sunnyvale California 94086 —
GSK Investigational Site Ukiah California 95482 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Yorba Linda California 92886 —
GSK Investigational Site Boulder Colorado 80304 —
GSK Investigational Site Denver Colorado 80209 —
GSK Investigational Site Denver Colorado 80220 —
GSK Investigational Site Englewood Colorado 80110 —
GSK Investigational Site Longmont Colorado 80501 —
GSK Investigational Site Wheat Ridge Colorado 80033 —
GSK Investigational Site Wheat Ridge Colorado 80043 —
GSK Investigational Site Washington D.C. District of Columbia 20003 —
GSK Investigational Site Washington D.C. District of Columbia 20037 —
GSK Investigational Site Fort Myers Florida 33907 —
GSK Investigational Site Hollywood Florida 33023 —
GSK Investigational Site Jacksonville Florida 32204 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Melbourne Florida 32935 —
GSK Investigational Site Miami Florida 33136 —
GSK Investigational Site Miami Florida 33176 —
GSK Investigational Site Orlando Florida 32806 —
GSK Investigational Site Palm Harbor Florida 34683 —
GSK Investigational Site Sarasota Florida 34239 —
GSK Investigational Site St. Petersburg Florida 33702 —
GSK Investigational Site St. Petersburg Florida 33710 —
GSK Investigational Site Tampa Florida 33612 —
GSK Investigational Site Titusville Florida 32796 —
GSK Investigational Site West Palm Beach Florida 33401 —
GSK Investigational Site Atlanta Georgia 30308 —
GSK Investigational Site Atlanta Georgia 30312 —
GSK Investigational Site Atlanta Georgia 30322 —
GSK Investigational Site Atlanta Georgia 30328 —
GSK Investigational Site Atlanta Georgia 30338 —
GSK Investigational Site Blue Ridge Georgia 30513 —
GSK Investigational Site Dunwoody Georgia 30338 —
GSK Investigational Site Fayetteville Georgia 30214 —
GSK Investigational Site Honolulu Hawaii 96813 —
GSK Investigational Site Boise Idaho 83706 —
GSK Investigational Site Chicago Illinois 60612 —
GSK Investigational Site Gurnee Illinois 60031 —
GSK Investigational Site Springfield Illinois 62704 —
GSK Investigational Site Evansville Indiana 47713 —
GSK Investigational Site Indianapolis Indiana 46202 —
GSK Investigational Site Indianapolis Indiana 46250 —
GSK Investigational Site Lexington Kentucky 40504-2681 —
GSK Investigational Site Lake Charles Louisiana 70601 —
GSK Investigational Site New Orleans Louisiana 70119 —
GSK Investigational Site Slidell Louisiana 70458 —
GSK Investigational Site Slidell Louisiana 70461 —
GSK Investigational Site Bangor Maine 04401 —
GSK Investigational Site Baltimore Maryland 21201 —
GSK Investigational Site Baltimore Maryland 21204 —
GSK Investigational Site Baltimore Maryland 21205 —
GSK Investigational Site Baltimore Maryland 21208 —
GSK Investigational Site Boston Massachusetts 02114 —
GSK Investigational Site Springfield Massachusetts 01199 —
GSK Investigational Site Ann Arbor Michigan 48109 —
GSK Investigational Site Detroit Michigan 48201 —
GSK Investigational Site Lansing Michigan 48912 —
GSK Investigational Site Royal Oak Michigan 48073 —
GSK Investigational Site Minneapolis Minnesota 55404 —
GSK Investigational Site Minneapolis Minnesota 55407-3799 —
GSK Investigational Site Minneapolis Minnesota 55416 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Olive Branch Mississippi 38654 —
GSK Investigational Site Kansas City Missouri 64132 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site St Louis Missouri 63128 —
GSK Investigational Site Billings Montana 59102 —
GSK Investigational Site Omaha Nebraska 68105 —
GSK Investigational Site Omaha Nebraska 68131 —
GSK Investigational Site Henderson Nevada 89014 —
GSK Investigational Site Cherry Hill New Jersey 08034 —
GSK Investigational Site Cherry Hill New Jersey 8034 —
GSK Investigational Site Albuquerque New Mexico 87102 —
GSK Investigational Site Albuquerque New Mexico 87106 —
GSK Investigational Site Albuquerque New Mexico 87109 —
GSK Investigational Site Albany New York 12206 —
GSK Investigational Site Endwell New York 13760 —
GSK Investigational Site Flushing New York 11365 —
GSK Investigational Site New York New York 10003 —
GSK Investigational Site New York New York 10010 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site New York New York 10029 —
GSK Investigational Site New York New York 10032 —
GSK Investigational Site Rochester New York 14609 —
GSK Investigational Site Rochester New York 14642 —
GSK Investigational Site Syracuse New York 13210 —
GSK Investigational Site The Bronx New York 10461 —
GSK Investigational Site Durham North Carolina 27710 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Cleveland Ohio 44121 —
GSK Investigational Site Cleveland Ohio 44195 —
GSK Investigational Site Mogadore Ohio 44260 —
GSK Investigational Site Westlake Ohio 44145 —
GSK Investigational Site Oklahoma City Oklahoma 73104 —
GSK Investigational Site Bend Oregon 97701 —
GSK Investigational Site Eugene Oregon 97401 —
GSK Investigational Site Portland Oregon 97219 —
GSK Investigational Site Portland Oregon 97239 —
GSK Investigational Site Downingtown Pennsylvania 19335 —
GSK Investigational Site Feasterville Pennsylvania 19053 —
GSK Investigational Site Fleetwood Pennsylvania 19522 —
GSK Investigational Site Hermitage Pennsylvania 16148 —
GSK Investigational Site Hershey Pennsylvania 17033 —
GSK Investigational Site Jefferson Hills Pennsylvania 15025 —
GSK Investigational Site Philadelphia Pennsylvania 19104 —
GSK Investigational Site Philadelphia Pennsylvania 19107 —
GSK Investigational Site Philadelphia Pennsylvania 19115 —
GSK Investigational Site Philadelphia Pennsylvania 19148 —
GSK Investigational Site Pittsburgh Pennsylvania 15219 —
GSK Investigational Site Upland Pennsylvania 19013 —
GSK Investigational Site Warminster Pennsylvania 18974 —
GSK Investigational Site West Chester Pennsylvania 19380 —
GSK Investigational Site Charleston South Carolina 29403 —
GSK Investigational Site Columbia South Carolina 29201 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Spartanburg South Carolina 29303 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Nashville Tennessee 37211 —
GSK Investigational Site Arlington Texas 76014 —
GSK Investigational Site Austin Texas 78745 —
GSK Investigational Site Beaumont Texas 77701 —
GSK Investigational Site Corpus Christi Texas 78411 —
GSK Investigational Site Corpus Christi Texas 78412 —
GSK Investigational Site Dallas Texas 75230 —
GSK Investigational Site Dallas Texas 75231 —
GSK Investigational Site Dallas Texas 75390 —
GSK Investigational Site Fort Worth Texas 76107 —
GSK Investigational Site Houston Texas 77024 —
GSK Investigational Site Houston Texas 77030 —
GSK Investigational Site Irving Texas 75061 —
GSK Investigational Site Midland Texas 79705 —
GSK Investigational Site San Antonio Texas 78207 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Ogden Utah 84403 —
GSK Investigational Site Salt Lake City Utah 84103 —
GSK Investigational Site Salt Lake City Utah 84108 —
GSK Investigational Site Charlottesville Virginia 22908 —
GSK Investigational Site Newport News Virginia 23606 —
GSK Investigational Site Richmond Virginia 23249 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Federal Way Washington 98003 —
GSK Investigational Site Seattle Washington 98104 —
GSK Investigational Site Seattle Washington 98108 —
GSK Investigational Site Seattle Washington 98195 —
GSK Investigational Site Spokane Washington 99204 —
GSK Investigational Site Spokane Washington 99207 —
GSK Investigational Site Spokane Washington 99208 —
GSK Investigational Site Wenatchee Washington 98801 —
GSK Investigational Site Charleston West Virginia 25304 —
GSK Investigational Site Huntington West Virginia 25701 —
GSK Investigational Site Madison Wisconsin 53717 —
GSK Investigational Site Milwaukee Wisconsin 53209 —
GSK Investigational Site Oregon Wisconsin 53575 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 312 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00279045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00279045 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →